Paving the Way for Diversity in Clinical Trials

“I’m the first person in my circle of family and friends to participate in a clinical trial.” Five years ago, Rhonda Long was diagnosed with cholangiocarcinoma, a rare bile duct cancer that’s seen in only about 8,000 Americans each year. At the time, Long, who is Black, said her doctor in Dayton, OH, told her she was not a candidate […]

Read more

Lucrin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. LUCRIN┬« INJECTION Leuprorelin acetate Consumer Medicine Information (CMI) What is in this leaflet This leaflet answers some common questions about Lucrin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks […]

Read more

GenRx Cyproterone 100mg

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GENRX CYPROTERONE 100 MG TABLETS Contains the active ingredient cyproterone (as cyproterone acetate) Consumer Medicine Information   What is in this leaflet Read this leaflet carefully before taking your medicine. This leaflet answers some common questions about cyproterone. It does not contain all the available information. It […]

Read more

Gold Nanoparticles Use in Prostate Cancer

Prostate cancer is one of the top four most common cancers globally. The increased use of testing has led to a greater number of cases being detected and requiring treatment. New treatment shows promising outcomes for men diagnosed with low or immediate-risk prostate cancer. Image Credit: Kateryna Kon/Shutterstock.com Using Gold Nanoparticles to Treat Prostate Cancer A novel pilot clinical trial […]

Read more

Screening mammography could benefit men at high risk of breast cancer

Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a landmark study published in the journal Radiology. Breast cancer in men is a rare but often deadly disease. The American Cancer Society projects that 2,670 new cases of invasive breast cancer will be diagnosed in […]

Read more

Novel anti-cancer nanomedicine for efficient chemotherapy

Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University,Finland and Huazhong University of Science and Technology,China have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy. This new nano-tool provides a new approach to use cell-based nanomedicines for effcient cancer chemotherapy. Exosomes contain various molecular constituents of their cell of origin, including proteins and RNA. […]

Read more

Patients taking nivolumab experience five-fold increase in overall survival compared to chemotherapy: Five-year outcomes from the randomized, phase 3 trials checkmate 017/057: nivolumab vs. docetaxel in previously treated NSCLC

Pooled data on two clinical trials demonstrate patients taking nivolumab realized a greater than five-fold increase in five-year overall survival rate compared with the chemotherapy docetaxel. The presentation was made today by Dr. Scott Gettinger of Yale Comprehensive Cancer Center, New Haven, Conn., at the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study […]

Read more

Gold nanoparticles shown to be safe and effective treatment for prostate cancer

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the journal Proceedings of the National Academy of Sciences. This treatment could offer patients a targeted therapy option that would preserve […]

Read more

A simpler way to choose the sex of offspring by separating X and Y sperm: Differential gene activity by the two sex chromosomes allows X-bearing sperm to be slowed down

A simple, reversible chemical treatment can segregate X-bearing sperm from Y-bearing sperm, allowing dramatic alteration of the normal 50/50 male/female offspring ratio, according to a new study by Masayuki Shimada and colleagues at Hiroshima University, published on August 13 in the open-access journal PLOS Biology. The study was performed in mice, but the technique is likely to be widely applicable […]

Read more
1 2 3 4